Floatz logo

Dexmedetomidine

Neuralgia

Universidad Juárez Autónoma de TabascoSmall moleculePhase 4 / ApprovedActive
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
64/ 100
Competitive Position
95/ 100

Competitive context

48 Active assets in the Neuralgia cohort.

Asset / SponsorPhaseRating
MIDAZOLAM
Minia University
Phase 4BBB
LIDOCAINE
Ataturk University
Phase 4BBB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Margaux M. Salas, PhD
Phase 4BBB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Medipol University
Phase 4BBB
Pregabalin
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 4BBB

View all 50 →

Same molecule, other indications

Dexmedetomidine is also rated in:

schizophreniform disorderDormant
A
Indicative ·
80 / 100
View asset →
schizoaffective disorderDormant
BBB
Indicative ·
77 / 100
View asset →
liver cancerDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →